# AviSia Therapeutics jobs and careers

> 0 open roles at AviSia Therapeutics as of October 23, 2026. Source: https://www.thejobsmap.com/company/avisia-therapeutics

At AviSia Therapeutics we develop antigen-specific immunotherapies for the treatment of autoimmune diseases. Our innovative solution uses glycans, complex carbohydrate structures that act as recognition elements for cellular communication to reprogram dendritic cells (DCs) and restore tolerance. The approach is based on scientific results provided by the group of Prof. Yvette van Kooyk (CSO of AviSia Therapeutics and Head of Molecular Cell Biology and Immunology Department at AUMC) and is protected by a strong IP portfolio with tremendous applications across multiple indications. Type 1 Diabetes (T1D) was selected as the first indication that we will focus on and we have already obtained promising results in this indication.

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Headquarters | Netherlands |
| Employees | 1 to 10 |
| Website | https://avisiatherapeutics.com |

## Leadership

- Yvette van Kooyk, Chief Scientific Officer

## Common questions

### Is AviSia Therapeutics hiring right now?

AviSia Therapeutics has no open roles listed as of October 23, 2026. Roles appear here as soon as they are posted on AviSia Therapeutics's careers site.

### Where is AviSia Therapeutics headquartered?

AviSia Therapeutics is headquartered in Netherlands.

### Who leads AviSia Therapeutics?

Yvette van Kooyk, Chief Scientific Officer, is at the top of AviSia Therapeutics's org chart.

### How do I apply for a job at AviSia Therapeutics?

Pick a role on AviSia Therapeutics's TheJobsMap page and select Apply. Every listing links to the original posting on AviSia Therapeutics's own careers site, so you apply directly with the employer.